These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 29910040)

  • 21. Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial.
    Gaudry S; Hajage D; Martin-Lefevre L; Lebbah S; Louis G; Moschietto S; Titeca-Beauport D; Combe B; Pons B; de Prost N; Besset S; Combes A; Robine A; Beuzelin M; Badie J; Chevrel G; Bohé J; Coupez E; Chudeau N; Barbar S; Vinsonneau C; Forel JM; Thevenin D; Boulet E; Lakhal K; Aissaoui N; Grange S; Leone M; Lacave G; Nseir S; Poirson F; Mayaux J; Asehnoune K; Geri G; Klouche K; Thiery G; Argaud L; Rozec B; Cadoz C; Andreu P; Reignier J; Ricard JD; Quenot JP; Dreyfuss D
    Lancet; 2021 Apr; 397(10281):1293-1300. PubMed ID: 33812488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
    Needham CJ; Brindley PG
    Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial.
    Asehnoune K; Seguin P; Allary J; Feuillet F; Lasocki S; Cook F; Floch H; Chabanne R; Geeraerts T; Roger C; Perrigault PF; Hanouz JL; Lukaszewicz AC; Biais M; Boucheix P; Dahyot-Fizelier C; Capdevila X; Mahe PJ; Le Maguet P; Paugam-Burtz C; Gergaud S; Plaud B; Constantin JM; Malledant Y; Flet L; Sebille V; Roquilly A;
    Lancet Respir Med; 2014 Sep; 2(9):706-16. PubMed ID: 25066331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of two strategies for initiating renal replacement therapy in the intensive care unit: study protocol for a randomized controlled trial (AKIKI).
    Gaudry S; Hajage D; Schortgen F; Martin-Lefevre L; Tubach F; Pons B; Boulet E; Boyer A; Lerolle N; Chevrel G; Carpentier D; Lautrette A; Bretagnol A; Mayaux J; Thirion M; Markowicz P; Thomas G; Dellamonica J; Richecoeur J; Darmon M; de Prost N; Yonis H; Megarbane B; Loubières Y; Blayau C; Maizel J; Zuber B; Nseir S; Bigé N; Hoffmann I; Ricard JD; Dreyfuss D
    Trials; 2015 Apr; 16():170. PubMed ID: 25902813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The use of sodium bicarbonate in stages in treating hypoperfusion induced lactic acidemia in septic shock].
    Chen XF; Ye JL; Zhu ZY
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jan; 25(1):24-7. PubMed ID: 23611092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study.
    Cooper DJ; Walley KR; Wiggs BR; Russell JA
    Ann Intern Med; 1990 Apr; 112(7):492-8. PubMed ID: 2156475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does sodium bicarbonate infusion really have no effect on the incidence of acute kidney injury after cardiac surgery? A prospective observational trial.
    Wetz AJ; Bräuer A; Quintel M; Heise D
    Crit Care; 2015 Apr; 19(1):183. PubMed ID: 25899029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study.
    Di Iorio BR; Bellasi A; Raphael KL; Santoro D; Aucella F; Garofano L; Ceccarelli M; Di Lullo L; Capolongo G; Di Iorio M; Guastaferro P; Capasso G;
    J Nephrol; 2019 Dec; 32(6):989-1001. PubMed ID: 31598912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The increase in CO2 production induced by NaHCO3 depends on blood albumin and hemoglobin concentrations.
    Levraut J; Garcia P; Giunti C; Ichai C; Bouregba M; Ciebiera JP; Payan P; Grimaud D
    Intensive Care Med; 2000 May; 26(5):558-64. PubMed ID: 10923730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
    Ueki K; Sasako T; Okazaki Y; Kato M; Okahata S; Katsuyama H; Haraguchi M; Morita A; Ohashi K; Hara K; Morise A; Izumi K; Ishizuka N; Ohashi Y; Noda M; Kadowaki T;
    Lancet Diabetes Endocrinol; 2017 Dec; 5(12):951-964. PubMed ID: 29079252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial.
    Dimopoulos MA; Goldschmidt H; Niesvizky R; Joshua D; Chng WJ; Oriol A; Orlowski RZ; Ludwig H; Facon T; Hajek R; Weisel K; Hungria V; Minuk L; Feng S; Zahlten-Kumeli A; Kimball AS; Moreau P
    Lancet Oncol; 2017 Oct; 18(10):1327-1337. PubMed ID: 28843768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium Bicarbonate for Metabolic Acidosis in the ICU: Results of a Pilot Randomized Double-Blind Clinical Trial.
    Serpa Neto A; Fujii T; McNamara M; Moore J; Young PJ; Peake S; Bailey M; Hodgson C; Higgins AM; See EJ; Secombe P; Campbell L; Young M; Maeda M; Pilcher D; Nichol A; Deane A; Licari E; White K; French C; Shehabi Y; Cross A; Maiden M; Kadam U; El Khawas K; Cooper J; Bellomo R; Udy A
    Crit Care Med; 2023 Nov; 51(11):e221-e233. PubMed ID: 37294139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit.
    Gaudry S; Hajage D; Schortgen F; Martin-Lefevre L; Pons B; Boulet E; Boyer A; Chevrel G; Lerolle N; Carpentier D; de Prost N; Lautrette A; Bretagnol A; Mayaux J; Nseir S; Megarbane B; Thirion M; Forel JM; Maizel J; Yonis H; Markowicz P; Thiery G; Tubach F; Ricard JD; Dreyfuss D;
    N Engl J Med; 2016 Jul; 375(2):122-33. PubMed ID: 27181456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical efficacy of sodium bicarbonate in treating pediatric metabolic acidosis with varying level of acid-base balance parameters: a real-world study.
    Liu H; Cao Y; Xue X; Bai Z; Wu S
    BMC Med; 2023 Nov; 21(1):473. PubMed ID: 38031038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study).
    Gaggl M; Cejka D; Plischke M; Heinze G; Fraunschiel M; Schmidt A; Hörl WH; Sunder-Plassmann G
    Trials; 2013 Jul; 14():196. PubMed ID: 23826760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial.
    Kantarjian HM; Roboz GJ; Kropf PL; Yee KWL; O'Connell CL; Tibes R; Walsh KJ; Podoltsev NA; Griffiths EA; Jabbour E; Garcia-Manero G; Rizzieri D; Stock W; Savona MR; Rosenblat TL; Berdeja JG; Ravandi F; Rock EP; Hao Y; Azab M; Issa JJ
    Lancet Oncol; 2017 Oct; 18(10):1317-1326. PubMed ID: 28844816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis (the BiCARB trial)? Study protocol for a randomized controlled trial.
    Witham MD; Band MM; Littleford RC; Avenell A; Soiza RL; McMurdo ME; Sumukadas D; Ogston SA; Lamb EJ; Hampson G; McNamee P;
    Trials; 2015 Aug; 16():326. PubMed ID: 26231610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continued enteral nutrition until extubation compared with fasting before extubation in patients in the intensive care unit: an open-label, cluster-randomised, parallel-group, non-inferiority trial.
    Landais M; Nay MA; Auchabie J; Hubert N; Frerou A; Yehia A; Mercat A; Jonas M; Martino F; Moriconi M; Courte A; Robert-Edan V; Conia A; Bavozet F; Egreteau PY; Bruel C; Renault A; Huet O; Feller M; Chudeau N; Ferrandiere M; Rebion A; Robert A; Giraudeau B; Reignier J; Thille AW; Tavernier E; Ehrmann S;
    Lancet Respir Med; 2023 Apr; 11(4):319-328. PubMed ID: 36693402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.
    Pivot X; Romieu G; Debled M; Pierga JY; Kerbrat P; Bachelot T; Lortholary A; Espié M; Fumoleau P; Serin D; Jacquin JP; Jouannaud C; Rios M; Abadie-Lacourtoisie S; Tubiana-Mathieu N; Cany L; Catala S; Khayat D; Pauporté I; Kramar A;
    Lancet Oncol; 2013 Jul; 14(8):741-8. PubMed ID: 23764181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study.
    Moreau P; Mateos MV; Berenson JR; Weisel K; Lazzaro A; Song K; Dimopoulos MA; Huang M; Zahlten-Kumeli A; Stewart AK
    Lancet Oncol; 2018 Jul; 19(7):953-964. PubMed ID: 29866475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.